Patents by Inventor Jeremy Colin Brownlie

Jeremy Colin Brownlie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified arthropod and method of use
    Patent number: 9090911
    Abstract: A modified arthropod, an arthropod-modifying bacterium, and use thereof as an agent for control of diseases transmitted by arthropods, particularly mosquitoes, is provided. More specifically, an isolated arthropod-adapted Wolbachia bacterium capable of modifying one or more biological properties of a mosquito host is provided. The modified arthropod may be characterized as having a shortened life-span, a reduced ability to transmit disease, a reduced susceptibility to a pathogen, a reduced fecundity, and/or a reduced ability to feed from a host, when compared to a corresponding wild-type arthropod.
    Type: Grant
    Filed: June 14, 2014
    Date of Patent: July 28, 2015
    Assignee: Monash University
    Inventors: Scott Leslie O'Neill, Conor James McMeniman, Karyn Nicole Johnson, Elizabeth Ann McGraw, Luciano A. Moreira, Peter Anthony Ryan, Brian Herbert Kay, Jeremy Colin Brownlie
  • MODIFIED ARTHROPOD AND METHOD OF USE
    Publication number: 20140298501
    Abstract: A modified arthropod, an arthropod-modifying bacterium, and use thereof as an agent for control of diseases transmitted by arthropods, particularly mosquitoes, is provided. More specifically, an isolated arthropod-adapted Wolbachia bacterium capable of modifying one or more biological properties of a mosquito host is provided. The modified arthropod may be characterized as having a shortened life-span, a reduced ability to transmit disease, a reduced susceptibility to a pathogen, a reduced fecundity, and/or a reduced ability to feed from a host, when compared to a corresponding wild-type arthropod.
    Type: Application
    Filed: June 14, 2014
    Publication date: October 2, 2014
    Inventors: Scott Leslie O'Neill, Conor James McMeniman, Karyn Nicole Johnson, Elizabeth Ann McGraw, Luciano A. Moreira, Peter Anthony Ryan, Brian Herbert Kay, Jeremy Colin Brownlie
  • Malathion carboxylesterase
    Patent number: 7091025
    Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethyloxon organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc?E 7, in which the protein encoded by the DNA molecule differs from E 3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 15, 2006
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Robyn Joyce Russell, Richard David Newcomb, Peter Malcolm Campbell, Geoffrey Charles de Quetteville Robin, Charles Claudianos, Kerrie-Anne Smyth, Thomas Mark Boyce, John Graham Oakeshott, Jeremy Colin Brownlie
  • Malathion carboxylesterase
    Publication number: 20030143711
    Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethylol organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc?E 7, in which the protein encoded by the DNA molecule differs from E 3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.
    Type: Application
    Filed: February 6, 2001
    Publication date: July 31, 2003
    Applicant: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Robyn Joyce Russell, Richard David Newcomb, Peter Malcolm Campbell, Geoffrey Charles de Quetteville Robin, Charles Claudianos, Kerrie-Ann Smyth, Thomas Mark Boyce, John Graham Oakeshott, Jeremy Colin Brownlie
  • Malathion carboxylesterase
    Patent number: 6235515
    Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethyloxon organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc&agr;E7, in which the protein encoded by the DNA molecule differs from E3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: May 22, 2001
    Assignee: The Commonwealth Scientific and Industrial Research Organization
    Inventors: Robyn Joyce Russell, Richard David Newcomb, Peter Malcolm Campbell, Geoffrey Charles de Quetteville Robin, Charles Claudianos, Kerrie-Ann Smyth, Thomas Mark Boyce, John Graham Oakeshott, Jeremy Colin Brownlie